Sign In
Buy HCA
$361.83
-1.40 (-0.385%)
At Close: Jun 04, 2026
This Stock Soared in August. Is It Still a Buy?
07:47am, Thursday, 01'st Sep 2022
This industry-leading company can weather a challenging operating environment.
Healthcare inflation is the latest price hike hitting consumers grappling with rising costs
07:59pm, Saturday, 27'th Aug 2022 MarketWatch
Inflation pressures are heating up in healthcare. Prices for care paid by private insurance jumped in July; premium hikes expected next year
Glenn Greenberg Is Going All In on This Subprime Lending Giant
04:17pm, Friday, 26'th Aug 2022
Glenn Greenberg (Trades, Portfolio)'s Brave Warrior Advisors recently disclosed its 13F portfolio updates for the second quarter of 2022, which ended on June 30.
Why Is Universal Health Services (UHS) Down 5.3% Since Last Earnings Report?
03:30pm, Wednesday, 24'th Aug 2022 Zacks Investment Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
17 Analysts Have This to Say About HCA Healthcare
02:30pm, Wednesday, 24'th Aug 2022 Benzinga
Over the past 3 months, 17 analysts have published their opinion on HCA Healthcare (NYSE:HCA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a co
Here's Why You Should Buy McKesson (MCK) Stock Right Now
02:22pm, Tuesday, 23'rd Aug 2022 Zacks Investment Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
The Most-Bought Guru Stocks of the 2nd Quarter
05:52pm, Friday, 19'th Aug 2022
The second quarter of 2022 saw the U.S. Federal Reserve continue hiking interest rates as inflation remained sky-high. Unless companies can raise their profits more than 9% year over year to surpass i
HCA Healthcare, Inc. to Present at September Healthcare Conference
04:30pm, Thursday, 18'th Aug 2022
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference: September 13, 2022 at 8:35 am EDT at the Morgan Stanley 20th Annual
Pediatrix (MD) Up 8% Since Q2 Earnings Release, Revenues Up Y/Y
05:49pm, Tuesday, 16'th Aug 2022 Zacks Investment Research
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
10 defensive stocks that can also provide you with growth and dividends over the long term
01:34pm, Saturday, 13'th Aug 2022 MarketWatch
Professional money managers have a strong preference for one stock sector in particular, along with cash dividends.
3 of the S&P 500's Top-Performing Stocks in July
02:00pm, Wednesday, 10'th Aug 2022 The Motley Fool
None of them, however, are outperforming the S&P this year.
10 defensive stocks that can also provide you with growth and dividends over the long term
10:05am, Wednesday, 10'th Aug 2022
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
01:37pm, Sunday, 07'th Aug 2022 The Motley Fool
Although they have moved in opposite directions this year, these two stocks should outperform for much of the next decade.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
09:37am, Sunday, 07'th Aug 2022
Although they have moved in opposite directions this year, these two stocks should outperform for much of the next decade.
ZoomInfo To $63? Plus Barclays Predicts This PT For Procter & Gamble
01:05pm, Tuesday, 02'nd Aug 2022 Benzinga
Barclays cut the price target for The Procter & Gamble Company (NYSE: PG) from $157 to $154. Procter & Gamble shares fell 0.5% to $142.25 in pre-market trading.
RBC Capital lowered the price target o
